AAGP 2026 Geriatric Psychiatry Board Review Course
Pricing
Information
Date & Time
-
-
-
-
Google
Outlook.com
Yahoo
Description
The AAGP Board Review Course in Geriatric Psychiatry is a comprehensive, high-yield educational program designed to support clinicians preparing for the geriatric psychiatry board examination and those seeking an up-to-date review of core clinical topics.
Offered as a live webinar every two years, the course provides a structured review of essential content across the evaluation, diagnosis, and treatment of psychiatric conditions in older adults.
Sessions are led by experienced, board-certified geriatric psychiatrists who are nationally recognized educators in the field. The curriculum focuses on evidence-based practice and includes board-style self-assessment questions to help participants assess their knowledge, identify learning gaps, and reinforce key concepts. This course is ideal for geriatric psychiatrists, fellows, and other healthcare professionals who care for aging adults and want a practical, focused review to strengthen clinical competence and exam readiness.
Learning Objectives
Participants will be able to:
-
Session 1: Describe physiologic changes associated with normal aging across major organ systems.
-
Session 1: Differentiate normal age-related cognitive changes from abnormal or pathological cognitive decline.
-
Session 1: Identify expected changes in sleep architecture and sleep patterns associated with normal aging.
-
Session 1: Apply principles of age-related physiologic and psychological change when making prescribing decisions in older adults.
-
Session 2: Describe the prevalence of older age bipolar disorder in different clinical populations.
-
Session 2: Identify and describe the varying clinical presentations of older age bipolar disorder.
-
Session 2: Recognize and explain common cognitive and medical comorbidities associated with older-age bipolar disorder.
-
Session 2: Apply evidence-based pharmacological and non-pharmacological strategies to the clinical management of older age bipolar disorder
-
Session 3: Describe and identify common anxiety disorders in the elderly.
-
Session 3: Utilize preferred pharmacologic interventions to treat anxiety.
-
Session 3: Apply at least two effective psychotherapy modalities for treating geriatric anxiety.
-
Session 4: Describe how the assessment and treatment of Major Depressive Disorder in Later Life (Late Life Depression or LLD) differs in older adults.
-
Session 4: List evidence-based pharmacologic and nonpharmacologic treatments for Late Life Depression and describe the benefits and adverse effects of each.
-
Session 4: Differentiate grief from complicated grief and from bereavement and discuss evidence-based treatments for complicated grief.
-
Session 4: Identify the distinctive epidemiology, risk factors, and methods of late-life suicide.
-
Session 5: Identify and diagnose personality disorders in older adults and their hallmark features.
-
Session 5: Differentiate personality disorders from other psychiatric disorders of late life including the impact of neurocognitive disorders on maladaptive personality traits.
-
Session 5: Determine appropriate pharmacologic and nonpharmacologic interventions for older adults with personality disorders.
-
Session 6: Differentiate the indications, efficacy, and safety profiles of electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), for the treatment of late-life mood disorders, including treatment-resistant depression.
-
Session 6: Apply evidence-based principles of ECT practice in older adults by selecting appropriate electrode placement, dosing strategies, continuation treatments, and cognitive monitoring approaches based on patient-specific clinical factors.
-
Session 6: Identify and manage common medical, cognitive, and neuropsychiatric complications associated with ECT in geriatric patients, incorporating risk-mitigation strategies and post-treatment relapse prevention plans.
-
Session 7: List the components of the neurological exam that are commonly relevant in the assessment of older individuals with psychiatric presentations
-
Session 7: Describe approaches to psychiatric evaluations that integrate neurological assessments
-
Session 7: Relate knowledge of neurological deficits that affect the mental status exam to localized brain lesions.
-
Session 7: Evaluate gait and movement abnormalities in older adults with neuropsychiatric presentations and propose a differential diagnosis
-
Session 8: Recognize the etiology, clinical features and diagnostics in the continuum from age-associated cognitive impairment to mild cognitive impairment to dementia.
-
Session 8: Describe the clinical indications, adverse effects and effectiveness of cognitive enhancing medications and disease modifying treatments in management of Alzheimer's disease and related dementias.
-
Session 8: Define the common neurobehavioral manifestations in dementia and use of psychotropic medications in the management.
-
Session 8: Determine the scope of non pharmacological interventions in management of dementia.
-
Session 9: Identify the diagnostic criteria and clinical features of psychosis in older adults.
-
Session 9: Select evidence-based pharmacologic and non-pharmacologic treatments for psychotic disorders in older adults.
-
Session 9: Compare three age-related schizophrenia spectrum disorders, including onset, course, and clinical presentation.
-
Session 10: Formulate ethical questions using the standard principles of medical ethics.
-
Session 10: Examine issues of proxy decision-making using common legal concepts of guardianship, durable power of attorney, and living wills.
-
Session 10: Evaluate medical capacity for decision-making in order to provide better care to patients who may have impaired cognition.
-
Session 11: Define elder abuse and recognize its major forms
-
Session 11: Identify key warning signs and risk factors associated with elder abuse
-
Session 11: Describe appropriate prevention, reporting and intervention strategies to protect vulnerable elders
-
Session 12: Explain the major phases of the stages of sleep and identify the properties of normal EEG waveforms.
-
Session 12: Explain the six EEG sleep changes frequently observed in older adults.
-
Session 12: Explain the differences between the major core features of CBT-I.
-
Session 12: Identify common sleep disorders that are often encountered and underdiagnosed in the care of older adults.
-
Session 13: Apply diagnostic criteria to accurately diagnose substance use disorders in older adults.
-
Session 13: Identify and implement interventions to treat older adults with substance use disorders.
-
Session 13: Apply diagnostic criteria to accurately diagnose comorbid psychiatric conditions in older adults.
-
Session 13: Identify and implement interventions to treat older adults with comorbid psychiatric conditions.
-
Session 14: Define and distinguish key terms in hospice and palliative medicine (HPM), including palliative care, hospice, and primary palliative care, as they are tested on board-style clinical scenarios.
-
Session 14: Identify settings and models of palliative care delivery and recognize how these models apply to common exam vignettes involving older adults with serious illness.
-
Session 14: Describe the hospice model, including core eligibility criteria and levels of care, with attention to common board-relevant misconceptions.
Target Audience
- Addiction Professional
- Counselor
- Fellows in geriatric psychiatry who are preparing for board exams or exploring advanced clinical content.
- Geriatric psychiatrists seeking to refresh or deepen their knowledge of core clinical topics in aging-related mental health.
- Marriage & Family Therapist
- Nurse
- Other healthcare professionals involved in the care of aging adults who want practical, evidence-based review material, including clinicians treating older patients and those seeking to strengthen clinical competence.
- Physician
- Psychologist
- Social Worker
Presenters
Dr. Subler is passionate about integrating psychiatry, medicine, and neurology to provide comprehensive care for older adults experiencing complex psychiatric and neuropsychiatric conditions. She is committed to a patient-centered and family-centered approach, working collaboratively with patients and their loved ones to develop customized, holistic treatment plans. She values building genuine relationships with her patients and strives to ensure that their personal values and goals remain central to the care they receive.
In addition to her clinical work, Dr. Subler is dedicated to training the next generation of healthcare providers. She works with medical students and resident physicians at Ohio State Harding Hospital and in the neuropsychiatric clinic at Ohio State’s Olentangy location. Her passion for teaching is one of the many reasons she enjoys working in academic medicine.
Dr. Gatchel’s research is focused on understanding the relationships among Alzheimer’s Disease (AD)-associated proteins amyloid and tau, neuropsychiatric symptoms, and cognitive decline in the preclinical and prodromal stages of AD and related dementias. She is utilizing a combination of neuroimaging and detailed clinical and neuropsychological assessments, towards developing better prevention and treatment strategies for individuals at risk for AD. Dr. Gatchel is the recipient of the HMS Department of Psychiatry Dupont Warren Fellowship and Livingston Award, the BrightFocus Foundation Research Fellowship, and the Alzheimer’s AssociationClinical Fellowship. She received the 2016 New Investigator award in Neuropsychiatric Symptoms in Neurodegenerative Diseases from the Alzheimer’s Association, and the 2017 Outstanding Emerging Research Scientist Award from the Bright Focus Foundation.
In her clinical role, Dr. Gatchel sees older adult patients with mood and cognitive disorders and utilizes transcranial magnetic stimulation to treat depression. She is passionate about advocating for patients with dementia and their families, promoting healthy brain aging and positive mental health, and training the next generation of geriatric psychiatrists and clinician-researchers. In her spare time, she enjoys spending time with family and friends, cooking and sampling cuisines, being amused by her Russian blue cats, Cosmo and Whiskers, and pursuing the most beautiful beaches, near and far.
Dr. Bogunovic’s scholarly work and primary area of clinical innovation is in two major areas of investigation: developing effective treatments for benzodiazepine use disorders and developing innovative treatments for elderly patients with substance use disorders.
Dr. Marsh graduated from Ohio State University College of Medicine, completed her Psychiatry Residency at Johns Hopkins University School of Medicine and clinical research fellowship training at the National Institute of Mental Health and at Stanford University School of Medicine. After her fellowships, she was an Assistant Professor at Stanford until 1998, when she returned to Johns Hopkins in Baltimore, MD as an Associate Professor and directed the Clinical Research Program of a NIH-funded Morris K. Udall Parkinson’s Disease Research Center. In 2009, Dr. Marsh moved to Houston for her current position. Dr. Marsh has published widely on psychiatric aspects of PD and served on advisory boards for Parkinson Foundation and American Parkinson’s Disease Association for many years. Locally, she is a member of the Houston Area Parkinson’s Society (HAPS) Medical Advisory Board, the Houston Workgroup for the SAMHSA-VA Mayors’ Challenge to Prevent Suicide in Veterans, Family Members and Caregivers, and the Homeless Cross System Planning Group coordinated by the Houston Downtown Management District and Houston/Harris County Coalition for Homeless.
Dr. Gopalakrishna is board-certified in adult psychiatry, geriatric psychiatry and addiction medicine. He has served as faculty at University of Missouri-Columbia and University of Arizona.
His research interests include administrative psychiatry, neurocognitive disorders and use of technology in mental health.
Dr. Krain completed a residency in General Psychiatry at the University of Michigan, Ann Arbor and completed a two year fellowship in Geriatric Psychiatry from the University Of Michigan, Ann Arbor.
Dr. Diaz is board-certified in General Psychiatry by the American Board of Psychiatry and Neurology, with subspecialty certification in Geriatric Psychiatry. Dr. Diaz has co-authored several peer-reviewed publications and presents nationally in the areas of general and geriatric psychiatry. Dr. Diaz is involved in the education of medical students and psychiatry residents. On a national level, she is involved with the American Association of Geriatric Psychiatry, serving on the Teaching and Training Committee and the Scholars Program for trainees.
She is an active partner in Emory’s Movement Disorders division and is a member of the Parkinson’s Disease Comprehensive Care Clinic. She is conducting research on Huntington’s Disease (HD) with the Emory HD Center of Excellence.
Financially Sponsored By
- American Association for Geriatric Psychiatry (AAGP)